Today: 9 April 2026
Synopsys stock rises as CEO flags export curbs, points to March Converge event
13 January 2026
2 mins read

Synopsys stock rises as CEO flags export curbs, points to March Converge event

New York, Jan 12, 2026, 21:23 EST — Market closed.

  • Shares of Synopsys climbed 1.6% by Monday’s close
  • In the 2025 shareholder letter, the CEO highlights export restrictions and “execution challenges.”
  • Investors are focused on the Jan. 15 Needham conference, looking for new signs of demand and updates on integration progress

Synopsys (SNPS.O) ended Monday 1.6% higher at $533.42 as investors digested a shareholder letter from CEO Sassine Ghazi. He highlighted “export restrictions” adding “a measure of uncertainty” to 2025 and flagged “execution challenges.” Ghazi also announced the company will showcase its integrated Synopsys-Ansys platform at a “Synopsys Converge” event in Silicon Valley this March. Synopsys Investor Relations

Timing is key. Export restrictions now heavily influence chip tools and design software sectors, with investors scrambling to assess how much disruption is already priced into forecasts for 2026.

Synopsys provides electronic design automation (EDA) software, which engineers rely on to design and verify chips digitally before manufacturing. The company is also ramping up efforts in simulation, a tool that models how products perform in real-world conditions.

Ignite Next announced Monday that Synopsys is now part of its European scale-up program, joining Intel and Infineon as a “focus technology collaborator.” Synopsys Chief Strategy Officer Antonio Varas highlighted the growing impact of nimble deep tech startups on breakthroughs in semiconductors, AI, and advanced computing. PR Newswire

Synopsys wrapped up its acquisition of Ansys in July 2025, stating the move would broaden its addressable market and accelerate an integrated technology roadmap. The company also said combined capabilities are expected to roll out in the first half of 2026, with Ansys shares set to stop trading on Nasdaq.

Synopsys projected fiscal 2026 revenue between $9.56 billion and $9.66 billion in December, with non-GAAP earnings per share expected to land from $14.32 to $14.40. This includes an anticipated $2.9 billion in revenue from Ansys. The non-GAAP numbers leave out items like acquisition-related amortization. The company also noted that these targets assume no additional shifts in export controls or U.S. “Entity List” restrictions.

In December, Nvidia poured $2 billion into Synopsys stock, buying shares at $414.79 each, deepening a partnership centered on GPU-accelerated simulation and “agentic” AI workflows, the companies announced. Nvidia CEO Jensen Huang remarked, “CUDA GPU-accelerated computing is revolutionizing design.”

Tech stocks edged up, with the Invesco QQQ Trust gaining roughly 0.1% and the iShares Semiconductor ETF climbing around 0.5%. Synopsys outperformed them both.

Synopsys is set to present at the 28th Annual Needham Growth Conference on Jan. 15 at 11:15 a.m. Pacific time. The company will stream the webcast on its investor relations page. Investors will be keen to catch any firmer comments on export controls and early updates on how the Ansys integration is progressing. Synopsys Investor Relations

New U.S. export restrictions or delays in deploying integrated tools could cast doubt on the company’s targets. The stock remains highly reactive to news tied to China.

Synopsys goes head-to-head mainly with Cadence Design Systems in EDA tools, though big industrial software players like Siemens also field competing platforms. Orders in this space often serve as a leading indicator of chip design activity, well ahead of wafer production.

Tuesday’s session centers on whether Monday’s bounce can stick as traders unpack the shareholder letter. The next major event on the calendar is the Needham appearance on Jan. 15, followed by the March Silicon Valley customer event.

Stock Market Today

  • Morgan Stanley's Ridham Desai Predicts Sensex at 95,000 by Dec 2026 Amid Bull Market Signal
    April 9, 2026, 6:01 AM EDT. Morgan Stanley strategist Ridham Desai forecasts the Sensex could reach 95,000 by December 2026, marking a 22% gain from the current level of 77,563. This target reflects a valuation at 23.5 times trailing earnings, slightly above the historical average of 22 times. The firm highlights India's nearly worst 12-month relative stock performance in history but notes a potential market recovery driven by stable macroeconomic factors, earnings growth, and steady policy environment. Key growth drivers include fiscal discipline, private investment, and robust domestic demand. The bull scenario sees the index soaring to 107,000 on stronger growth and lower oil prices, while risks such as high crude prices and a potential US recession could drag it down to 76,000. Overall, Indian equities appear undervalued and positioned for a rebound according to Morgan Stanley.

Latest article

India Stock Market Today: Sensex Drops Over 1,100 Points, Nifty Slips as Oil Rebound Revives Risk Fears

India Stock Market Today: Sensex Drops Over 1,100 Points, Nifty Slips as Oil Rebound Revives Risk Fears

9 April 2026
Indian stocks fell sharply Thursday afternoon, with the Sensex down 1.51% and the Nifty 50 off 1.12% as oil prices rebounded and U.S.-Iran ceasefire concerns resurfaced. Financials and IT shares led declines, with HDFC Bank, SBI, and ICICI Bank losing up to 2.27%. The World Bank warned the West Asia crisis threatens India’s growth and inflation outlook. India imports about 90% of its oil.
Australia Stock Market Today: ASX 200 Ends at Five-Week High as Banks Offset Tech Rout

Australia Stock Market Today: ASX 200 Ends at Five-Week High as Banks Offset Tech Rout

9 April 2026
The S&P/ASX 200 closed up 0.2% at 8,973.20 on Thursday, a five-week high, led by gains in banks while tech shares slumped. Bendigo and Adelaide Bank surged 9.5% after reporting higher earnings and job cuts. Energy stocks rose as oil rebounded, but trading volumes stayed below average. Investors remained cautious amid ongoing Middle East tensions and uncertain oil supply routes.
UK Stock Market Today: FTSE 100 Holds Near 10,600 as Oil Rebound Tests Ceasefire Rally

UK Stock Market Today: FTSE 100 Holds Near 10,600 as Oil Rebound Tests Ceasefire Rally

9 April 2026
FTSE 100 held near 10,600 Thursday after a 2.5% rally to a one-month high, outperforming European peers as Germany’s DAX and France’s CAC 40 fell. Brent crude rebounded toward $98 on renewed U.S.-Iran ceasefire doubts. A Bank of England survey showed lenders expect mortgage demand to rise in Q2. British builders faced record cost inflation in March.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 6:14 AM EDT Morgan Stanley's Ridham Desai Predicts Sensex at 95,000 by Dec 2026 Amid Bull Market Signal April 9, 2026, 6:01 AM EDT. Morgan Stanley strategist Ridham Desai forecasts the Sensex could reach 95,000 by December 2026, marking a 22% gain from the current level of 77,563. This target reflects a valuation at 23.5 times trailing earnings, slightly above the historical average of 22 times. The firm highlights India's nearly worst 12-month relative stock performance in history but notes a potential market recovery driven by stable macroeconomic
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal
Previous Story

Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda
Next Story

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Go toTop